Connect Biopharma Holdings Ltd CNTB Price Prediction & Forecast



Forecast

CNTB Stock Price Prediction

Connect Biopharma Holdings Ltd

0%

$0

At close: May 01, 16:00:00 GMT-4

0%

$0

Post-market: May 01, 20:00:00 GMT-4

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is CNTB?

Connect Biopharma Holdings Ltd. operates as clinical-stage biopharmaceutical company. The company is headquartered in San Diego, California and currently employs 62 full-time employees. The company went IPO on 2021-03-19. The firm is focused on advancing rademikibart, a potentially best-in-class next generation anti-interleukin-4-receptor alpha (IL-4Rα) antibody, to transform acute and chronic care in asthma and chronic obstructive pulmonary disease (COPD). Its lead product candidate, rademikibart, is an antibody designed to target interleukin-4 receptor alpha (IL-4Rα) in development for the treatment of atopic dermatitis (AD) and asthma. As an inhibitor of IL-4Rα, rademikibart blocks inflammatory signaling by both IL-4 and IL-13. The firm has completed a global Phase II trial (CBP-201-WW001) of rademikibart in adult patients with moderate-to-severe AD.

Features

Markets

News

CNTB Stock Price Prediction Summary

CNTB stock price ended at $0 on Saturday, after dropping NaN%

On the latest trading day May 02, 2026, the stock price of CNTB fell by NaN%, dropping from $NaN to $NaN. During the session, the stock saw a volatility of NaN%, with prices oscillating between a daily low of $NaN and a high of $NaN. On the latest trading day, the trading volume for CNTB decreased by -- shares, aligning with the declining prices, which may indicate weakening market confidence in the near term. In total, -- shares were traded, with a market value of approximately --.

CNTB Technical Signals

Technical Signals Summary

Buy Signals 0

Neutral Signals 7

Sell Signals 0

Strong Sell

Sell

Neutral

Buy

Strong Buy

CNTB currently exhibits 0 buy signals and 0 sell signals. The stock has been in an downtrend since --, with a total price change of -- during this period. Overall, the technical indicators point to a Neutral outlook for the mid-term.

Bullish/Bearish Signals for CNTB

Our algorithms analyze key indicators like moving averages, RSI, MACD, and trading volume to generate bullish and bearish signals for CNTB. These insights help you make informed investment decisions.

Follow-Up Questions

How do technical analysis indicators apply to CNTB?



According to technical analysis, Connect Biopharma Holdings Ltd has an aggregate signal of Neutral. Connect Biopharma Holdings Ltd has 0 Buy signals, 7 Neutral Signals and 0 sell signals.

What is the RSI for Connect Biopharma Holdings Ltd?



The RSI for Connect Biopharma Holdings Ltd is currently 0, indicating a neutral condition

What is Connect Biopharma Holdings Ltd price for the next 12 months?



Connect Biopharma Holdings Ltd CNTB price for the next 12 months is estimated at $0.

How high is Connect Biopharma Holdings Ltd expected to go?



According to wall street analysts, Connect Biopharma Holdings Ltd is expected to reach a high forecast of $0.

Connect Biopharma Holdings Ltd (CNTB) Stock Price Prediction

CNTB Stock Price Chart